⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Global enterprises join Talogy to rethink High Potential talent at SIOP Conference 2026 USA - English India - English
prnewswire.com
WMT
NKE
JNJ
OC
Precision Cardiovascular Appoints Brian Fahey, Ph.D., as Independent Director to the Board
prnewswire.com
JNJ
Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study
globenewswire.com
JNJ
Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study
prnewswire.com
JNJ
Johnson & Johnson presents new data further reinforcing the role of nipocalimab in lowering the autoantibodies driving Sjögren's disease
prnewswire.com
JNJ
El Meijer LPGA Classic for Simply Give 2026 regresa con las experiencias familiares favoritas de los fanáticos USA - español USA - English
prnewswire.com
V
MSFT
GOOG
AMZN
M
TGT
WMT
KR
COST
PG
JNJ
KO
PEP
MCD
SBUX
DIS
CMCSA
NFLX
AMAT
NVDA
INTC
AMD
QCOM
MU
TXN
ADI
NXPI
MRVL
SNPS
CDNS
ASML
LRCX
KLAC
AMGN
GILD
BMY
PFE
MRK
ABBV
LLY
JPM
BAC
WFC
C
GS
MS
AXP
IBM
ORCL
CRM
CSCO
ACN
ADP
NOW
ADBE
EA
TTWO
CRSP
REGN
VRTX
BIIB
ALGN
EXPE
BKNG
MAR
HPE
DELL
HPQ
AVGO
ADSK
PAYX
FISV
PYPL
MELI
EBAY
BABA
JD
PDD
NIO
XPEV
LI
TSLA
RIVN
LCID
GM
F
STLA
TM
HMC
VWAGY
BBD
AAPL
META
SNAP
PINS
Myasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight
globenewswire.com
IMVT
ROIV
MRK
NVS
REGN
UCB
JNJ
ARGX
AMGN
VIR
IPHA
ARWR
APLS
CABA
L’étude de la Phase 3 menée par Johnson & Johnson sur le cancer de la prostate montre qu’ERLEADA® (apalutamide), administré avant et après la chirurgie, réduit considérablement le risque de métastases ou de décès par rapport à l’hormonothérapie seule, ce
globenewswire.com
JNJ
Form 8-K
sec.gov
ONCY
CGON
AMGN
JNJ
Rhythm AI Appoints Medtech Veteran Mike Dineen as Chief Executive Officer
prnewswire.com
JNJ
ABT
MED